Login / Signup

Cost-of-Illness Progression Before and After Diagnosis of Multiple Sclerosis: A Nationwide Register-Based Cohort Study in Sweden of People Newly Diagnosed with Multiple Sclerosis and a Population-Based Matched Reference Group.

Chantelle MurleyPetter TinghögKristina AlexandersonJan HillertEmilie FribergKorinna Karampampa
Published in: PharmacoEconomics (2021)
Excess healthcare costs and productivity losses occur already before the diagnosis of MS and increase with time. The excess costs findings before diagnosis could suggest that an earlier diagnosis might lead to reduced excess costs of MS over time.
Keyphrases
  • multiple sclerosis
  • healthcare
  • newly diagnosed
  • mass spectrometry
  • ms ms
  • white matter
  • climate change
  • social media
  • health information